Cardio Diagnostics Holdings, Inc. Deferred Tax Assets, Operating Loss Carryforwards
Cardio Diagnostics Holdings, Inc. (CDIO) had Deferred Tax Assets, Operating Loss Carryforwards of $6.68 million as of 2025-12-31, per its 10-K filed 2026-03-13.
Financial Statements › Notes › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-13
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $6.68M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $5.58M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $4.22M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $1.61M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $6.68M 10-K · filed 2026-03-13 | |
| 2024-12-31 | $5.58M 10-K · filed 2026-03-13 | |
| 2023-12-31 | $4.22M 10-K · filed 2025-03-20 | |
| 2022-12-31 | $1.61M 10-K · filed 2024-04-01 | |
| 2021-12-31 | $146.58K 10-K · filed 2023-03-31 | $30.42K 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |